nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertindole—DRD3—Parkinson's disease	0.209	0.283	CbGaD
Sertindole—HTR1A—Parkinson's disease	0.171	0.231	CbGaD
Sertindole—DRD2—Parkinson's disease	0.145	0.196	CbGaD
Sertindole—HTR2A—Parkinson's disease	0.112	0.151	CbGaD
Sertindole—CYP2D6—Parkinson's disease	0.102	0.138	CbGaD
Sertindole—DRD3—telencephalic ventricle—Parkinson's disease	0.00409	0.0445	CbGeAlD
Sertindole—HTR2A—enteric nervous system—Parkinson's disease	0.00365	0.0397	CbGeAlD
Sertindole—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00276	0.0301	CbGeAlD
Sertindole—HTR2A—locus ceruleus—Parkinson's disease	0.00241	0.0262	CbGeAlD
Sertindole—HTR1B—telencephalic ventricle—Parkinson's disease	0.00237	0.0258	CbGeAlD
Sertindole—HTR1D—telencephalic ventricle—Parkinson's disease	0.0023	0.025	CbGeAlD
Sertindole—HTR2C—telencephalic ventricle—Parkinson's disease	0.00228	0.0248	CbGeAlD
Sertindole—HTR2A—cerebellar cortex—Parkinson's disease	0.00196	0.0214	CbGeAlD
Sertindole—HTR1A—telencephalic ventricle—Parkinson's disease	0.00192	0.0209	CbGeAlD
Sertindole—HTR2A—sympathetic nervous system—Parkinson's disease	0.0019	0.0207	CbGeAlD
Sertindole—DRD2—telencephalic ventricle—Parkinson's disease	0.00173	0.0188	CbGeAlD
Sertindole—HTR1F—forebrain—Parkinson's disease	0.00151	0.0165	CbGeAlD
Sertindole—HTR2A—pons—Parkinson's disease	0.00139	0.0151	CbGeAlD
Sertindole—HTR1E—brainstem—Parkinson's disease	0.00136	0.0148	CbGeAlD
Sertindole—HTR1E—forebrain—Parkinson's disease	0.00131	0.0143	CbGeAlD
Sertindole—HTR2A—autonomic nervous system—Parkinson's disease	0.00128	0.0139	CbGeAlD
Sertindole—HTR2A—telencephalic ventricle—Parkinson's disease	0.00114	0.0124	CbGeAlD
Sertindole—DRD2—nerve—Parkinson's disease	0.00109	0.0119	CbGeAlD
Sertindole—ADRA2A—peripheral nervous system—Parkinson's disease	0.00109	0.0118	CbGeAlD
Sertindole—HTR6—forebrain—Parkinson's disease	0.00103	0.0112	CbGeAlD
Sertindole—SLC6A4—hindbrain—Parkinson's disease	0.00102	0.0111	CbGeAlD
Sertindole—HTR2A—peripheral nervous system—Parkinson's disease	0.000923	0.01	CbGeAlD
Sertindole—HTR1A—hindbrain—Parkinson's disease	0.000905	0.00984	CbGeAlD
Sertindole—Haloperidol—GRIN2B—Parkinson's disease	0.000902	0.138	CrCbGaD
Sertindole—HTR1F—head—Parkinson's disease	0.000867	0.00943	CbGeAlD
Sertindole—ADRA1A—hindbrain—Parkinson's disease	0.000834	0.00907	CbGeAlD
Sertindole—HTR1F—nervous system—Parkinson's disease	0.000822	0.00894	CbGeAlD
Sertindole—DRD2—hindbrain—Parkinson's disease	0.000817	0.00889	CbGeAlD
Sertindole—ADRA1D—forebrain—Parkinson's disease	0.000803	0.00874	CbGeAlD
Sertindole—HTR1F—central nervous system—Parkinson's disease	0.000791	0.00861	CbGeAlD
Sertindole—HTR1E—head—Parkinson's disease	0.000751	0.00817	CbGeAlD
Sertindole—HTR2A—nerve—Parkinson's disease	0.00072	0.00783	CbGeAlD
Sertindole—HTR1E—nervous system—Parkinson's disease	0.000712	0.00774	CbGeAlD
Sertindole—HTR1E—central nervous system—Parkinson's disease	0.000685	0.00746	CbGeAlD
Sertindole—HTR1B—brainstem—Parkinson's disease	0.000643	0.00699	CbGeAlD
Sertindole—DRD4—brain—Parkinson's disease	0.000631	0.00686	CbGeAlD
Sertindole—HTR1F—brain—Parkinson's disease	0.000628	0.00683	CbGeAlD
Sertindole—HTR1D—brainstem—Parkinson's disease	0.000622	0.00677	CbGeAlD
Sertindole—HTR1B—forebrain—Parkinson's disease	0.00062	0.00675	CbGeAlD
Sertindole—HTR2C—brainstem—Parkinson's disease	0.000616	0.0067	CbGeAlD
Sertindole—DRD3—head—Parkinson's disease	0.000612	0.00666	CbGeAlD
Sertindole—Domperidone—DRD3—Parkinson's disease	0.000601	0.0916	CrCbGaD
Sertindole—HTR1D—forebrain—Parkinson's disease	0.0006	0.00653	CbGeAlD
Sertindole—HTR2C—forebrain—Parkinson's disease	0.000595	0.00647	CbGeAlD
Sertindole—HTR6—head—Parkinson's disease	0.000589	0.00641	CbGeAlD
Sertindole—SLC6A4—brainstem—Parkinson's disease	0.000584	0.00635	CbGeAlD
Sertindole—DRD3—nervous system—Parkinson's disease	0.00058	0.00631	CbGeAlD
Sertindole—SLC6A4—forebrain—Parkinson's disease	0.000564	0.00613	CbGeAlD
Sertindole—DRD3—central nervous system—Parkinson's disease	0.000559	0.00608	CbGeAlD
Sertindole—HTR6—nervous system—Parkinson's disease	0.000559	0.00608	CbGeAlD
Sertindole—HTR1E—brain—Parkinson's disease	0.000544	0.00592	CbGeAlD
Sertindole—HTR2A—hindbrain—Parkinson's disease	0.000539	0.00587	CbGeAlD
Sertindole—HTR6—central nervous system—Parkinson's disease	0.000538	0.00585	CbGeAlD
Sertindole—HTR1B—cardiovascular system—Parkinson's disease	0.000524	0.00571	CbGeAlD
Sertindole—HTR1A—brainstem—Parkinson's disease	0.000519	0.00564	CbGeAlD
Sertindole—HTR1D—cardiovascular system—Parkinson's disease	0.000508	0.00552	CbGeAlD
Sertindole—Pimozide—DRD3—Parkinson's disease	0.000502	0.0765	CrCbGaD
Sertindole—HTR1A—forebrain—Parkinson's disease	0.0005	0.00545	CbGeAlD
Sertindole—CYP2D6—hindbrain—Parkinson's disease	0.000491	0.00534	CbGeAlD
Sertindole—ADRA1A—brainstem—Parkinson's disease	0.000478	0.0052	CbGeAlD
Sertindole—ADRA1B—head—Parkinson's disease	0.00047	0.00512	CbGeAlD
Sertindole—DRD2—brainstem—Parkinson's disease	0.000469	0.0051	CbGeAlD
Sertindole—ADRA1A—forebrain—Parkinson's disease	0.000461	0.00502	CbGeAlD
Sertindole—ADRA1D—head—Parkinson's disease	0.00046	0.005	CbGeAlD
Sertindole—Haloperidol—DRD3—Parkinson's disease	0.000458	0.0698	CrCbGaD
Sertindole—DRD2—forebrain—Parkinson's disease	0.000452	0.00492	CbGeAlD
Sertindole—Haloperidol—DRD1—Parkinson's disease	0.00045	0.0686	CrCbGaD
Sertindole—ADRA1B—nervous system—Parkinson's disease	0.000446	0.00485	CbGeAlD
Sertindole—KCNH2—forebrain—Parkinson's disease	0.000446	0.00485	CbGeAlD
Sertindole—DRD3—brain—Parkinson's disease	0.000444	0.00483	CbGeAlD
Sertindole—ADRA1D—nervous system—Parkinson's disease	0.000436	0.00474	CbGeAlD
Sertindole—HTR2C—medulla oblongata—Parkinson's disease	0.00043	0.00467	CbGeAlD
Sertindole—ADRA1B—central nervous system—Parkinson's disease	0.000429	0.00467	CbGeAlD
Sertindole—HTR6—brain—Parkinson's disease	0.000427	0.00465	CbGeAlD
Sertindole—HTR1A—cardiovascular system—Parkinson's disease	0.000423	0.0046	CbGeAlD
Sertindole—ADRA1D—central nervous system—Parkinson's disease	0.00042	0.00457	CbGeAlD
Sertindole—Domperidone—DRD2—Parkinson's disease	0.000416	0.0634	CrCbGaD
Sertindole—HTR1B—midbrain—Parkinson's disease	0.00041	0.00446	CbGeAlD
Sertindole—Pimozide—HTR1A—Parkinson's disease	0.000409	0.0624	CrCbGaD
Sertindole—HTR1B—spinal cord—Parkinson's disease	0.0004	0.00435	CbGeAlD
Sertindole—HTR1D—midbrain—Parkinson's disease	0.000396	0.00431	CbGeAlD
Sertindole—HTR2C—midbrain—Parkinson's disease	0.000393	0.00427	CbGeAlD
Sertindole—ADRA1A—cardiovascular system—Parkinson's disease	0.00039	0.00424	CbGeAlD
Sertindole—HTR2C—spinal cord—Parkinson's disease	0.000383	0.00417	CbGeAlD
Sertindole—KCNH2—cardiovascular system—Parkinson's disease	0.000377	0.0041	CbGeAlD
Sertindole—SLC6A4—midbrain—Parkinson's disease	0.000372	0.00405	CbGeAlD
Sertindole—SLC6A4—spinal cord—Parkinson's disease	0.000363	0.00395	CbGeAlD
Sertindole—HRH1—forebrain—Parkinson's disease	0.000357	0.00389	CbGeAlD
Sertindole—HTR1B—head—Parkinson's disease	0.000355	0.00386	CbGeAlD
Sertindole—ADRA2A—forebrain—Parkinson's disease	0.000351	0.00382	CbGeAlD
Sertindole—Pimozide—DRD2—Parkinson's disease	0.000347	0.053	CrCbGaD
Sertindole—HTR1D—head—Parkinson's disease	0.000344	0.00374	CbGeAlD
Sertindole—ADRA1B—brain—Parkinson's disease	0.000341	0.00371	CbGeAlD
Sertindole—HTR2C—head—Parkinson's disease	0.00034	0.0037	CbGeAlD
Sertindole—HTR2A—embryo—Parkinson's disease	0.000337	0.00367	CbGeAlD
Sertindole—HTR1B—nervous system—Parkinson's disease	0.000337	0.00366	CbGeAlD
Sertindole—Pimozide—CYP2E1—Parkinson's disease	0.000334	0.051	CrCbGaD
Sertindole—ADRA1D—brain—Parkinson's disease	0.000333	0.00363	CbGeAlD
Sertindole—HTR1A—midbrain—Parkinson's disease	0.00033	0.0036	CbGeAlD
Sertindole—HTR1D—nervous system—Parkinson's disease	0.000326	0.00355	CbGeAlD
Sertindole—HTR1B—central nervous system—Parkinson's disease	0.000324	0.00353	CbGeAlD
Sertindole—HTR2C—nervous system—Parkinson's disease	0.000323	0.00351	CbGeAlD
Sertindole—SLC6A4—head—Parkinson's disease	0.000323	0.00351	CbGeAlD
Sertindole—HTR1A—spinal cord—Parkinson's disease	0.000322	0.00351	CbGeAlD
Sertindole—KCNH2—medulla oblongata—Parkinson's disease	0.000322	0.0035	CbGeAlD
Sertindole—Haloperidol—DRD2—Parkinson's disease	0.000317	0.0483	CrCbGaD
Sertindole—HTR1D—central nervous system—Parkinson's disease	0.000314	0.00341	CbGeAlD
Sertindole—HTR2C—central nervous system—Parkinson's disease	0.000311	0.00338	CbGeAlD
Sertindole—HTR2A—brainstem—Parkinson's disease	0.000309	0.00336	CbGeAlD
Sertindole—SLC6A4—nervous system—Parkinson's disease	0.000306	0.00333	CbGeAlD
Sertindole—DRD2—midbrain—Parkinson's disease	0.000299	0.00325	CbGeAlD
Sertindole—HTR2A—forebrain—Parkinson's disease	0.000298	0.00325	CbGeAlD
Sertindole—SLC6A4—central nervous system—Parkinson's disease	0.000295	0.00321	CbGeAlD
Sertindole—KCNH2—midbrain—Parkinson's disease	0.000294	0.0032	CbGeAlD
Sertindole—Domperidone—CYP2D6—Parkinson's disease	0.000294	0.0448	CrCbGaD
Sertindole—KCNH2—spinal cord—Parkinson's disease	0.000287	0.00312	CbGeAlD
Sertindole—HTR1A—head—Parkinson's disease	0.000287	0.00312	CbGeAlD
Sertindole—CYP2D6—brainstem—Parkinson's disease	0.000282	0.00306	CbGeAlD
Sertindole—CYP2D6—forebrain—Parkinson's disease	0.000272	0.00296	CbGeAlD
Sertindole—HTR1A—nervous system—Parkinson's disease	0.000272	0.00296	CbGeAlD
Sertindole—Pimozide—HTR2A—Parkinson's disease	0.000268	0.0409	CrCbGaD
Sertindole—ADRA1A—head—Parkinson's disease	0.000264	0.00287	CbGeAlD
Sertindole—HTR1A—central nervous system—Parkinson's disease	0.000262	0.00285	CbGeAlD
Sertindole—DRD2—head—Parkinson's disease	0.000259	0.00282	CbGeAlD
Sertindole—HTR1B—brain—Parkinson's disease	0.000257	0.0028	CbGeAlD
Sertindole—HTR1A—cerebellum—Parkinson's disease	0.000256	0.00278	CbGeAlD
Sertindole—KCNH2—head—Parkinson's disease	0.000255	0.00278	CbGeAlD
Sertindole—ADRA2A—medulla oblongata—Parkinson's disease	0.000253	0.00276	CbGeAlD
Sertindole—HTR2A—cardiovascular system—Parkinson's disease	0.000252	0.00274	CbGeAlD
Sertindole—ADRA1A—nervous system—Parkinson's disease	0.00025	0.00272	CbGeAlD
Sertindole—HTR1D—brain—Parkinson's disease	0.000249	0.00271	CbGeAlD
Sertindole—HTR2C—brain—Parkinson's disease	0.000247	0.00268	CbGeAlD
Sertindole—DRD2—nervous system—Parkinson's disease	0.000245	0.00267	CbGeAlD
Sertindole—Pimozide—CYP2D6—Parkinson's disease	0.000245	0.0374	CrCbGaD
Sertindole—Haloperidol—HTR2A—Parkinson's disease	0.000245	0.0374	CrCbGaD
Sertindole—KCNH2—nervous system—Parkinson's disease	0.000242	0.00263	CbGeAlD
Sertindole—ADRA1A—central nervous system—Parkinson's disease	0.000241	0.00262	CbGeAlD
Sertindole—DRD2—central nervous system—Parkinson's disease	0.000236	0.00257	CbGeAlD
Sertindole—ADRA1A—cerebellum—Parkinson's disease	0.000236	0.00256	CbGeAlD
Sertindole—SLC6A4—brain—Parkinson's disease	0.000234	0.00254	CbGeAlD
Sertindole—KCNH2—central nervous system—Parkinson's disease	0.000233	0.00253	CbGeAlD
Sertindole—ADRA2A—midbrain—Parkinson's disease	0.000232	0.00252	CbGeAlD
Sertindole—DRD2—cerebellum—Parkinson's disease	0.000231	0.00251	CbGeAlD
Sertindole—KCNH2—cerebellum—Parkinson's disease	0.000228	0.00248	CbGeAlD
Sertindole—ADRA2A—spinal cord—Parkinson's disease	0.000226	0.00246	CbGeAlD
Sertindole—Haloperidol—CYP2D6—Parkinson's disease	0.000224	0.0342	CrCbGaD
Sertindole—HTR2A—medulla oblongata—Parkinson's disease	0.000215	0.00234	CbGeAlD
Sertindole—Domperidone—ABCB1—Parkinson's disease	0.00021	0.032	CrCbGaD
Sertindole—HTR1A—brain—Parkinson's disease	0.000208	0.00226	CbGeAlD
Sertindole—HRH1—head—Parkinson's disease	0.000204	0.00222	CbGeAlD
Sertindole—ADRA2A—head—Parkinson's disease	0.000201	0.00219	CbGeAlD
Sertindole—HTR2A—midbrain—Parkinson's disease	0.000197	0.00214	CbGeAlD
Sertindole—HRH1—nervous system—Parkinson's disease	0.000194	0.00211	CbGeAlD
Sertindole—HTR2A—spinal cord—Parkinson's disease	0.000192	0.00209	CbGeAlD
Sertindole—ADRA1A—brain—Parkinson's disease	0.000191	0.00208	CbGeAlD
Sertindole—ADRA2A—nervous system—Parkinson's disease	0.00019	0.00207	CbGeAlD
Sertindole—DRD2—brain—Parkinson's disease	0.000188	0.00204	CbGeAlD
Sertindole—HRH1—central nervous system—Parkinson's disease	0.000187	0.00203	CbGeAlD
Sertindole—KCNH2—brain—Parkinson's disease	0.000185	0.00201	CbGeAlD
Sertindole—ADRA2A—central nervous system—Parkinson's disease	0.000183	0.00199	CbGeAlD
Sertindole—ADRA2A—cerebellum—Parkinson's disease	0.000179	0.00195	CbGeAlD
Sertindole—Pimozide—ABCB1—Parkinson's disease	0.000175	0.0267	CrCbGaD
Sertindole—HTR2A—head—Parkinson's disease	0.000171	0.00186	CbGeAlD
Sertindole—HTR2A—nervous system—Parkinson's disease	0.000162	0.00176	CbGeAlD
Sertindole—Haloperidol—ABCB1—Parkinson's disease	0.00016	0.0244	CrCbGaD
Sertindole—HTR2A—central nervous system—Parkinson's disease	0.000156	0.0017	CbGeAlD
Sertindole—CYP2D6—head—Parkinson's disease	0.000156	0.00169	CbGeAlD
Sertindole—HTR2A—cerebellum—Parkinson's disease	0.000152	0.00166	CbGeAlD
Sertindole—CYP3A4—nervous system—Parkinson's disease	0.00015	0.00163	CbGeAlD
Sertindole—HRH1—brain—Parkinson's disease	0.000148	0.00161	CbGeAlD
Sertindole—CYP2D6—nervous system—Parkinson's disease	0.000147	0.0016	CbGeAlD
Sertindole—ADRA2A—brain—Parkinson's disease	0.000146	0.00158	CbGeAlD
Sertindole—CYP3A4—central nervous system—Parkinson's disease	0.000144	0.00157	CbGeAlD
Sertindole—CYP2D6—central nervous system—Parkinson's disease	0.000142	0.00155	CbGeAlD
Sertindole—CYP2D6—cerebellum—Parkinson's disease	0.000139	0.00151	CbGeAlD
Sertindole—HTR2A—brain—Parkinson's disease	0.000124	0.00135	CbGeAlD
Sertindole—CYP2D6—brain—Parkinson's disease	0.000113	0.00123	CbGeAlD
Sertindole—HRH1—Signaling Pathways—FGB—Parkinson's disease	8.21e-06	5.06e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—TAC1—Parkinson's disease	8.19e-06	5.05e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	8.19e-06	5.05e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	8.18e-06	5.04e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	8.16e-06	5.03e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	8.06e-06	4.97e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	8.05e-06	4.97e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—TAC1—Parkinson's disease	8.04e-06	4.96e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	8.03e-06	4.95e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—DRD1—Parkinson's disease	8.03e-06	4.95e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	8.01e-06	4.94e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	8.01e-06	4.94e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	8.01e-06	4.94e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—FBP1—Parkinson's disease	7.98e-06	4.92e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—DBH—Parkinson's disease	7.98e-06	4.92e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—GBA—Parkinson's disease	7.98e-06	4.92e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	7.97e-06	4.91e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	7.97e-06	4.91e-05	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—NGF—Parkinson's disease	7.96e-06	4.91e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	7.92e-06	4.88e-05	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—NGF—Parkinson's disease	7.9e-06	4.87e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	7.9e-06	4.87e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	7.89e-06	4.86e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—DRD1—Parkinson's disease	7.88e-06	4.86e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—ADRBK1—Parkinson's disease	7.88e-06	4.86e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	7.86e-06	4.85e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—DRD3—Parkinson's disease	7.78e-06	4.8e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—NQO1—Parkinson's disease	7.77e-06	4.79e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	7.74e-06	4.77e-05	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—NGF—Parkinson's disease	7.74e-06	4.77e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—IGF2—Parkinson's disease	7.7e-06	4.75e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—IGF2—Parkinson's disease	7.7e-06	4.75e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—TH—Parkinson's disease	7.66e-06	4.73e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	7.65e-06	4.72e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—DRD3—Parkinson's disease	7.63e-06	4.71e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—DRD2—Parkinson's disease	7.63e-06	4.7e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—HTR7—Parkinson's disease	7.63e-06	4.7e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	7.61e-06	4.7e-05	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—NGF—Parkinson's disease	7.61e-06	4.69e-05	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—HTR2A—Parkinson's disease	7.58e-06	4.67e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—MAOB—Parkinson's disease	7.54e-06	4.65e-05	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	7.52e-06	4.64e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	7.49e-06	4.62e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	7.48e-06	4.61e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	7.46e-06	4.6e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—IGF1R—Parkinson's disease	7.45e-06	4.59e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—IGF1R—Parkinson's disease	7.45e-06	4.59e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	7.44e-06	4.59e-05	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	7.36e-06	4.54e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—EDN1—Parkinson's disease	7.36e-06	4.54e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—EDN1—Parkinson's disease	7.36e-06	4.54e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—CYCS—Parkinson's disease	7.36e-06	4.54e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	7.33e-06	4.52e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	7.26e-06	4.48e-05	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—HTR2A—Parkinson's disease	7.25e-06	4.47e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	7.19e-06	4.43e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	7.14e-06	4.41e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	7.13e-06	4.4e-05	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—APOE—Parkinson's disease	7.05e-06	4.35e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—HTR7—Parkinson's disease	7.03e-06	4.34e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	7e-06	4.31e-05	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—APOE—Parkinson's disease	6.99e-06	4.31e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	6.96e-06	4.29e-05	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—CASP3—Parkinson's disease	6.95e-06	4.29e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	6.92e-06	4.27e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	6.92e-06	4.27e-05	CbGpPWpGaD
Sertindole—HTR1F—Signaling by GPCR—IL6—Parkinson's disease	6.91e-06	4.26e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—HTR7—Parkinson's disease	6.9e-06	4.26e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—DRD2—Parkinson's disease	6.9e-06	4.26e-05	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—APOE—Parkinson's disease	6.85e-06	4.22e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	6.78e-06	4.18e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	6.78e-06	4.18e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—NGF—Parkinson's disease	6.76e-06	4.17e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—NGF—Parkinson's disease	6.76e-06	4.17e-05	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—APOE—Parkinson's disease	6.74e-06	4.15e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	6.71e-06	4.14e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	6.68e-06	4.12e-05	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—CASP3—Parkinson's disease	6.56e-06	4.05e-05	CbGpPWpGaD
Sertindole—HTR1E—Signaling by GPCR—IL6—Parkinson's disease	6.52e-06	4.02e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—COMT—Parkinson's disease	6.51e-06	4.02e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	6.5e-06	4.01e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	6.49e-06	4e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—GSTP1—Parkinson's disease	6.48e-06	4e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—MAOA—Parkinson's disease	6.47e-06	3.99e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	6.46e-06	3.98e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	6.44e-06	3.97e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—HTR2A—Parkinson's disease	6.44e-06	3.97e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	6.41e-06	3.95e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—HMOX1—Parkinson's disease	6.39e-06	3.94e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	6.39e-06	3.94e-05	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—MAPK8—Parkinson's disease	6.39e-06	3.94e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	6.38e-06	3.93e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	6.3e-06	3.88e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	6.3e-06	3.88e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	6.18e-06	3.81e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—ABCB1—Parkinson's disease	6.14e-06	3.79e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	6.11e-06	3.77e-05	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—MAPK8—Parkinson's disease	6.03e-06	3.72e-05	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—INS—Parkinson's disease	6.02e-06	3.71e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—APOE—Parkinson's disease	5.98e-06	3.69e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—APOE—Parkinson's disease	5.98e-06	3.69e-05	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—INS—Parkinson's disease	5.97e-06	3.68e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—GSTM1—Parkinson's disease	5.96e-06	3.67e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—IGF2—Parkinson's disease	5.89e-06	3.63e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—NGF—Parkinson's disease	5.89e-06	3.63e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—NGF—Parkinson's disease	5.86e-06	3.62e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—DDC—Parkinson's disease	5.85e-06	3.61e-05	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—INS—Parkinson's disease	5.85e-06	3.61e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	5.8e-06	3.58e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—IGF2—Parkinson's disease	5.79e-06	3.57e-05	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—INS—Parkinson's disease	5.76e-06	3.55e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—GPX1—Parkinson's disease	5.71e-06	3.52e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	5.7e-06	3.51e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	5.68e-06	3.5e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—EDN1—Parkinson's disease	5.63e-06	3.47e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	5.61e-06	3.46e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	5.61e-06	3.46e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	5.61e-06	3.46e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	5.59e-06	3.45e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	5.58e-06	3.44e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	5.54e-06	3.42e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—GSTA4—Parkinson's disease	5.53e-06	3.41e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—EDN1—Parkinson's disease	5.53e-06	3.41e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—CTGF—Parkinson's disease	5.5e-06	3.39e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	5.49e-06	3.39e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	5.42e-06	3.35e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	5.34e-06	3.29e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	5.28e-06	3.25e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—MTHFR—Parkinson's disease	5.27e-06	3.25e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—APOE—Parkinson's disease	5.22e-06	3.22e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—APOE—Parkinson's disease	5.19e-06	3.2e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—NGF—Parkinson's disease	5.17e-06	3.19e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	5.12e-06	3.16e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—INS—Parkinson's disease	5.11e-06	3.15e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—INS—Parkinson's disease	5.11e-06	3.15e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	5.1e-06	3.15e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—NGF—Parkinson's disease	5.09e-06	3.14e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—NGF—Parkinson's disease	5.08e-06	3.13e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—NQO1—Parkinson's disease	5.07e-06	3.12e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	5.04e-06	3.11e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—TH—Parkinson's disease	4.99e-06	3.08e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	4.98e-06	3.07e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	4.98e-06	3.07e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	4.97e-06	3.06e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—MAOB—Parkinson's disease	4.93e-06	3.04e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	4.93e-06	3.04e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—APOE—Parkinson's disease	4.9e-06	3.02e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	4.84e-06	2.98e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—CYCS—Parkinson's disease	4.79e-06	2.96e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	4.75e-06	2.93e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	4.63e-06	2.86e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—APOE—Parkinson's disease	4.58e-06	2.82e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—APOE—Parkinson's disease	4.51e-06	2.78e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—APOE—Parkinson's disease	4.5e-06	2.77e-05	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—CASP3—Parkinson's disease	4.48e-06	2.76e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—INS—Parkinson's disease	4.46e-06	2.75e-05	CbGpPWpGaD
Sertindole—HTR6—Signaling by GPCR—IL6—Parkinson's disease	4.45e-06	2.75e-05	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	4.45e-06	2.74e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—INS—Parkinson's disease	4.43e-06	2.73e-05	CbGpPWpGaD
Sertindole—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	4.42e-06	2.72e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	4.41e-06	2.72e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	4.41e-06	2.72e-05	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	4.35e-06	2.69e-05	CbGpPWpGaD
Sertindole—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	4.33e-06	2.67e-05	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—CASP3—Parkinson's disease	4.29e-06	2.64e-05	CbGpPWpGaD
Sertindole—DRD4—Signaling by GPCR—IL6—Parkinson's disease	4.26e-06	2.63e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—COMT—Parkinson's disease	4.24e-06	2.62e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—INS—Parkinson's disease	4.24e-06	2.62e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—GSTP1—Parkinson's disease	4.22e-06	2.61e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—MAOA—Parkinson's disease	4.21e-06	2.6e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—INS—Parkinson's disease	4.19e-06	2.58e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—HMOX1—Parkinson's disease	4.17e-06	2.57e-05	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	4.12e-06	2.54e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	4.1e-06	2.53e-05	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	4.09e-06	2.52e-05	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—IL6—Parkinson's disease	4.08e-06	2.52e-05	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	4e-06	2.47e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—ABCB1—Parkinson's disease	4e-06	2.47e-05	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—MAPK8—Parkinson's disease	3.94e-06	2.43e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—INS—Parkinson's disease	3.91e-06	2.41e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—GSTM1—Parkinson's disease	3.88e-06	2.39e-05	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—IL6—Parkinson's disease	3.85e-06	2.37e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—INS—Parkinson's disease	3.85e-06	2.37e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—INS—Parkinson's disease	3.84e-06	2.37e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	3.81e-06	2.35e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—CASP3—Parkinson's disease	3.81e-06	2.35e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	3.78e-06	2.33e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling by GPCR—IL6—Parkinson's disease	3.78e-06	2.33e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—INS—Parkinson's disease	3.77e-06	2.32e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—GPX1—Parkinson's disease	3.72e-06	2.29e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	3.66e-06	2.26e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—CTGF—Parkinson's disease	3.59e-06	2.22e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—INS—Parkinson's disease	3.5e-06	2.16e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	3.5e-06	2.16e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	3.5e-06	2.16e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—MTHFR—Parkinson's disease	3.43e-06	2.12e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.35e-06	2.07e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	3.32e-06	2.05e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—NQO1—Parkinson's disease	3.31e-06	2.04e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	3.3e-06	2.04e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	3.3e-06	2.03e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	3.28e-06	2.02e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—TH—Parkinson's disease	3.26e-06	2.01e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—APOE—Parkinson's disease	3.19e-06	1.97e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	3.16e-06	1.95e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	3.14e-06	1.94e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.13e-06	1.93e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	3.05e-06	1.88e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	3.03e-06	1.87e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CASP3—Parkinson's disease	2.91e-06	1.8e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	2.9e-06	1.79e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—IL6—Parkinson's disease	2.89e-06	1.78e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	2.87e-06	1.77e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CASP3—Parkinson's disease	2.86e-06	1.76e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	2.85e-06	1.76e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—IL6—Parkinson's disease	2.84e-06	1.75e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	2.81e-06	1.73e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	2.79e-06	1.72e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—COMT—Parkinson's disease	2.78e-06	1.71e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—GSTP1—Parkinson's disease	2.76e-06	1.7e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—MAOA—Parkinson's disease	2.76e-06	1.7e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—INS—Parkinson's disease	2.73e-06	1.68e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.72e-06	1.68e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	2.68e-06	1.65e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	2.63e-06	1.62e-05	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—IL6—Parkinson's disease	2.63e-06	1.62e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	2.63e-06	1.62e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.61e-06	1.61e-05	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—IL6—Parkinson's disease	2.61e-06	1.61e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	2.61e-06	1.61e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	2.59e-06	1.6e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	2.58e-06	1.59e-05	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—IL6—Parkinson's disease	2.56e-06	1.58e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.54e-06	1.57e-05	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—IL6—Parkinson's disease	2.51e-06	1.55e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.43e-06	1.5e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	2.4e-06	1.48e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.24e-06	1.38e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	2.23e-06	1.38e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—IL6—Parkinson's disease	2.23e-06	1.38e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—APOE—Parkinson's disease	2.09e-06	1.29e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—IL6—Parkinson's disease	1.95e-06	1.2e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—IL6—Parkinson's disease	1.94e-06	1.19e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	1.85e-06	1.14e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—INS—Parkinson's disease	1.78e-06	1.1e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.71e-06	1.05e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.68e-06	1.04e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.68e-06	1.04e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	1.65e-06	1.02e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	1.53e-06	9.44e-06	CbGpPWpGaD
